Leading Pharmaceutical Innovation How to Win the Life Science Race /

This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management me...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: Gassmann, Oliver (Autor)
Médium: Elektronický zdroj E-kniha
Jazyk:angličtina
Vydáno: Cham : Springer International Publishing, 2018.
Vydání:3rd ed. 2018.
Témata:
ISBN:9783319668338
On-line přístup: Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

MARC

LEADER 00000nam a22000005i 4500
003 SK-BrCVT
005 20220618120631.0
007 cr nn 008mamaa
008 180510s2018 gw | s |||| 0|eng d
020 |a 9783319668338 
024 7 |a 10.1007/978-3-319-66833-8  |2 doi 
035 |a CVTIDW11075 
040 |a Springer-Nature  |b eng  |c CVTISR  |e AACR2 
041 |a eng 
100 1 |a Gassmann, Oliver.  |4 aut 
245 1 0 |a Leading Pharmaceutical Innovation  |h [electronic resource] :  |b How to Win the Life Science Race /  |c by Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer. 
250 |a 3rd ed. 2018. 
260 1 |a Cham :  |b Springer International Publishing,  |c 2018. 
300 |a XV, 179 p. 41 illus., 3 illus. in color.  |b online resource. 
500 |a Business and Management  
505 0 |a Innovation: Key to Success in the Pharmaceutical Industry -- The Industry Challenge: Who Would Want to Be in This Business?- The Science and Technology Challenge: How to Find New Drugs -- The Pipeline Challenge: How to Organize Innovation -- The Make-or-Buy Challenge: How to In- and Outsource Innovation -- The Open Innovation Challenge: How to Partner for Innovation -- The Internationalization Challenge: Where to Access Innovation -- Future Directions and Trends. 
516 |a text file PDF 
520 |a This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation. Health care innovation is possibly the greatest opportunity and challenge of our generation. This important book shows how pharmaceutical companies will continue to play an instrument role in making our lives better. Stefan Thomke, William Barclay Harding Professor of Business Administration, Harvard Business School Very comprehensive review and analysis of current challenges for the biopharmaceutical industry. To stay competitive in this new technology driven environment, the industry started to develop new partnership models to close the innovation gap and provide patients with the relevant healthcare toolkits at the convergence of pharmaceuticals, diagnostics and IT technologies. Very exciting times ahead well depicted in this book! Karima Boubekeur, VP Emerging Portfolio and Search & Evaluation, AstraZeneca Great. The 3rd edition is not only an update. It's an outstandingly featured summary on the challenges of pharma innovation. Eckard von Keutz, SVP and Head of Early Development, Bayer Healthcare. 
650 0 |a Management. 
650 0 |a Industrial management. 
650 0 |a Pharmaceutical technology. 
650 0 |a Pharmacy management. 
650 0 |a Pharmacy. 
650 0 |a Health care management. 
650 0 |a Health services administration. 
650 0 |a Health economics. 
856 4 0 |u http://hanproxy.cvtisr.sk/han/cvti-ebook-springer-eisbn-978-3-319-66833-8  |y Vzdialený prístup pre registrovaných používateľov 
910 |b ZE08355 
919 |a 978-3-319-66833-8 
974 |a andrea.lebedova  |f Elektronické zdroje 
992 |a SUD 
999 |c 275408  |d 275408